Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huoxue Qiyang Qutan is a Traditional Chinese Medicine (TCM) formula developed by the Shanghai Yueyang Integrated Traditional Chinese Medicine and Western Medicine Hospital. It is primarily designed to treat metabolic syndrome and associated conditions such as hypertension and erectile dysfunction. The formula's name reflects its therapeutic principles: "Huoxue" (invigorating blood), "Qiyang" (activating Yang/improving potency), and "Qutan" (eliminating phlegm). It is thought to work by improving vascular endothelial function, reducing inflammation, and regulating lipid metabolism. Clinical and preclinical studies have investigated its effects on blood pressure regulation and the improvement of erectile function in patients with metabolic disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huoxue Qiyang Qutan.